SCHEMBL17799649

SCHEMBL17799649

N#Cc1ccccc1C(=O)N[C@H]1CC[C@H]1c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPIA P62937 1/20 0.42
▸ FPR1 P21462 2/20 0.41
▸ FPR2 P25090 2/20 0.41
▸ EPHX2 P34913 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MC4R P32245 1/20 0.39
▸ CNR1 P21554 1/20 0.38
▸ PTGDR2 Q9Y5Y4 1/20 0.38
▸ DRD4 P21917 2/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ SENP8 Q96LD8 1/20 0.38
▸ SENP7 Q9BQF6 1/20 0.38
▸ SENP6 Q9GZR1 1/20 0.38
▸ LDHA P00338 1/20 0.37
▸ TAS1R3 Q7RTX0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16371991 1.00 PPIA (0.42) PPIAFPR1FPR2EPHX2KDM4E
SCHEMBL16372214 0.84 PPIA (0.41) PPIAEPHX2KDM4EALDH1A1GAA
SCHEMBL17799690 0.84 PPIA (0.41) PPIAEPHX2KDM4EALDH1A1GAA
SCHEMBL17799705 0.83 NPC1 (0.47) FPR1FPR2ALDH1A1FLT1
SCHEMBL17799762 0.81 SIGMAR1 (0.48) FPR1FPR2EPHX2CNR1DRD4
SCHEMBL16372277 0.81 SIGMAR1 (0.48) FPR1FPR2EPHX2CNR1DRD4
SCHEMBL17799637 0.81 GRM5 (0.47) PPIAFPR1FPR2ALDH1A1GAA
SCHEMBL16371986 0.81 NPC1 (0.51) FPR1FPR2GLAGAATAS1R3
SCHEMBL16372272 0.81 GRM5 (0.47) PPIAFPR1FPR2ALDH1A1GAA
SCHEMBL17799699 0.81 NPC1 (0.51) FPR1FPR2GLAGAATAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50724-E1 4-membered ring carboxamides used as nematicides SYNGENTA CROP PROTECTION AG (CH) 2026-01-06 — — US disclosed
EP-3019476-B1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2018-01-17 — — EP disclosed
US-9867371-B2 4-membered ring carboxamides used as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2018-01-16 — — US disclosed
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES TUBA3C, DDT, CYCS PPIA 890/4885FPR1 605/4885FPR2 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback